Navigation Links
Minority Biomedical Entrepreneurship Conference

CLEVELAND, March 19, 2012 /PRNewswire-USNewswire/ -- The nation's first Minority Biomedical Entrepreneurship Conference (MBEC), will convene May 21-22 in Cleveland.  MBEC offers a unique platform for minority professionals, entrepreneurs, investors, students and industry leaders to engage, network, collaborate and exchange ideas.


Minorities represent less than 5 percent(1) of the growing biomedical industry workforce, and a fraction of that number engages in entrepreneurial endeavors. To address the issue of underrepresentation, and to increase minority competitiveness in the biomedical industry, The America21 Project, a minority innovation and competitiveness initiative, and BioEnterprise, a biomedical business accelerator, partnered to created MBEC. The intent is to hold the conference annually.

Keynoting the conference is Dr. Frank Douglas, President of the Austen BioInnovation Institute and former Executive Vice President and Chief Scientific Officer of Aventis.  A national steering committee of Hispanic and African-American leaders in the biomedical industry – including Guy Fish, Vice President Fletcher Spaght Ventures (Boston); Ron Foy, Managing Director Cambria Capital (San Francisco); and Marissa Trevino, Founder Latina Lista (Dallas)- guide the conference mission and direct the agenda.   A nationally-recognized speaker line-up – including Dr. William L. Daley, Vice President Business Development & Licensing, U.S. Medical Affairs, Sanofi (New Jersey); and Monica Sturgis, HR Business Partner, Boehringer-Ingelheim (Cleveland) – complete an inspired conference agenda.

"Cleveland, with its rapidly growing biomedical industry and nationally recognized research, clinical and educational institutions, is the ideal location for the first-ever Minority Biomedical Entrepreneurship Conference," said Baiju R. Shah, President and CEO of BioEnterprise and Co-Chair of MBEC.  "The entrepreneurial environment  is one that embraces and provides an unparalleled support network to biomedical innovators."  

The Minority Biomedical Entrepreneurship Conference tackles many challenges minorities face in the biomedical industry. Attendees will be offered mentoring opportunities with industry leaders and investors, entrepreneurship education, and practical advice on starting and growing a biomedical company. Entrepreneurs looking for funding are afforded the opportunity to present before a group of seasoned biomedical investors. To view the complete conference agenda and register, visit

"The underrepresentation of African Americans and Latinos in the biomedical industry undermines national economic competitiveness," said Johnathan Holifield, a co-founder of The America21 Project and co-chair of MBEC. "MBEC confronts the problem by bringing minority entrepreneurs together with industry veterans and investors for mentoring, networking and education."

About The America21 Project:

America21, the first and only national voice for accelerating the growth of African American and Latino American prosperity through increased innovation capacity and economic competitiveness, has partnered with innovation ecosystem leadership organizations to seed Inclusive Competitiveness in Northeast Ohio and is similarly partnering with other regional innovation-based economic development organizations in additional urban regions, including Portland OR and Pittsburgh, PA. To learn more about The America21 Project, visit

About BioEnterprise:

BioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to health care companies.

BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, University Hospitals, Summa Health System, and the BioInnovation Institute in Akron.  Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio.  The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices:  the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group.  The combined efforts of these groups has created, recruited, and accelerated more than 100 companies in nine years. For more information see

(1) Diversity in Academic Biomedicine: An Evaluation of Education and Career Outcomes with Implications for Policy, Donna K. Ginther, Professor, Department of Economics, University of Kansas, September 22, 2009.

SOURCE BioEnterprise Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. HumanTouch Founder, President and CEO, Moe Jafari Named Washington Business Journal Minority Business Leader Honoree
2. Ohio Capital Fund Announces Sponsorship of Minority Business Conference
3. ECBC Now Accepting Applications for 2009 Minority Undergraduate Summer Internship Program
4. ZyGEM to Provide its Unique DNA and RNA Extraction Technology to Middle East Biomedical Innovator Saudi Diagnostics Ltd.
5. Scott Brooks Joins Regenesis Biomedical as Chief Operating Officer
6. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
7. Live Press Briefing on Findings of Biomedical Industry CEO Survey
8. Saladax Biomedical, Inc. to Present at Biotech Showcase™ 2012
9. Van Andel Institute Partners with UNCF to Recruit Students to Biomedical Research Careers
10. Roche NimbleGen and BGI Develop Advanced MHC Region Capture Technology for Human Disease and Biomedical Research
11. Saladax Biomedical, Inc. Appoints Li Zhang, M.D., to Scientific Advisory Board
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
(Date:11/24/2015)... 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) will ... New York on Wednesday, December 2 at 9:30 a.m. ... and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim Mazzola ... a corporate overview. --> th Annual Oppenheimer Healthcare ...
(Date:11/24/2015)... RALEIGH, N.C. , Nov. 24, 2015  Clintrax Global, Inc., ... Raleigh, North Carolina , today announced that the company has ... earnings represented a 391% quarter on quarter growth posted for Q3 ... Kingdom and Mexico , with the ... place in December 2015. --> United Kingdom ...
(Date:11/24/2015)... ALBANY, New York , November 24, 2015 /PRNewswire/ ... According to a recent market research report released by ... is projected to expand at a CAGR of 17.5% ... titled "Non-invasive Prenatal Testing Market - Global Industry Analysis, ... 2022", estimates the global non-invasive prenatal testing market to ...
Breaking Biology Technology:
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... , Oct. 29, 2015  Rubicon Genomics, Inc., ... U.S. distribution of its DNA library preparation products, ... Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX Plasma-seq has ... preparation of NGS libraries for liquid biopsies--the analysis ... and prognostic applications in cancer and other conditions. ...
(Date:10/29/2015)... 29, 2015 NXTD ) ... focused on the growing mobile commerce market and ... StackCommerce, a leading marketplace to discover and buy ... smart wallet on StackSocial for this holiday season. ... the "Company"), a biometric authentication company focused on ...
Breaking Biology News(10 mins):